First Quarter 2024 HighlightsALBUQUERQUE, N.M., May 09, 2024 (GLOBE NEWSWIRE) -- Array Technologies (NASDAQ: ARRY) (“Array” or “the Company”), a...
Contacts Anthony Sirica (212) 206-8800 ajsirica@arkrestaurants.com Ark Restaurants Corp. (NASDAQ:ARKR) will hold a conference call for investors and analysts to...
MAUMEE, Ohio, May 9, 2024 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) proudly announces the election of the company's President and...
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative...
Annual recurring revenue was $285 million, up 9% year over year First quarter revenue of $72.6 million, up 9% year...
THOUSAND OAKS, Calif., May 9, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global...
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq:...
AlTi continues to execute strategy to expand scale and reach of its global ultra-high-net-worth (“UHNW”) wealth management business in existing...
-- First quarter SaaS and license revenue increased 11.0% to $150.3 million, compared to $135.4 million for the first quarter...
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies...
First quarter revenue of $987 million, up 8% year-over-year and when adjusted for foreign exchange* Security and compute revenue represented 64% of...
Phase 3 epilepsy program continues to progress with anticipated completion of patient enrollment in X-TOLE2 in late 2024 to early...
CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results...
Q3 FY 2024 Net Revenues Totaled $211.2 MillionQ3 FY 2024 Gross Profit Increased to $28.0 Million and Gross Margin Improved...
Announces Delivery of First Commercial Products from Conway, AR Extract and Ready-to-Drink FacilityReaffirms 2024 Guidance; Issues Preliminary 2025 GuidanceRead more...
Contacts Investors: Myesha Lacy ir@arcellx.com 510-418-2412 Media: Andrea Cohen Sam Brown Inc. andreacohen@sambrown.com 917-209-7163 Arcellx, Inc. (NASDAQ: ACLX), a biotechnology...
ROCHESTER, N.Y., May 9, 2024 /PRNewswire/ --- Vuzix® Corporation (NASDAQ: VUZI) ("Vuzix" or the "Company"), a leading supplier of smart...
Company to Host Quarterly Conference Call at 5:00 P.M. ET on May 9, 2024 The information in this press release...
SEATTLE and VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical...
Phase 2a trials of CNS-Penetrant NLRP3 Inhibitor VTX3232 to initiate in H2 2024 in patients with early Parkinson’s disease and in...
Plan to announce topline RAMP 201 data with the start of planned rolling NDA submission for avutometinib and defactinib combination...
SUGAR LAND, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access...
Contacts The Bank of New York Mellon Trust Company, N.A. Sarah Newell 512-236-6555 sarah.newell@bnymellon.com Chesapeake Granite Wash Trust (OTC Markets...
BROSSARD, Quebec, May 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a...
Total Revenues Up 49% and Gross Booking Value Up 41% Year-Over-Year Leadership Transition, Capital Raise and Operational Streamlining Support Renewed...
RIO DE JANEIRO, May 9, 2024 /PRNewswire/ -- Vinci Partners Investments Ltd. (NASDAQ: VINP) ("Vinci Partners", "we", "us" or "our"),...
Contacts Investor Relations Contact ir@vacasa.com Press Contact pr@vacasa.com Vacasa, Inc. (Nasdaq: VCSA), North America’s leading vacation rental management platform, today...
SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Upwork Inc. (Nasdaq: UPWK), the world’s largest work marketplace that connects businesses...
- TYRA-300 on track in ACH and oncology; SURF301 Ph1 initial results and ACH IND submission expected in 2H24 -...
Contacts Investor Inquiries Daniel T. Noreck Chief Financial Officer TechTarget, Inc. 617-431-9449 dnoreck@techtarget.com investor@techtarget.com Media Inquiries Garrett Mann Director of...
MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on...
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA...
Q3’24 Financial Results and Recent Business HighlightsSAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Synaptics Incorporated (Nasdaq: SYNA), today...
Pivotal Phase 3 IMPALA-2 Trial Remains On-track, Top Line Results Expected by End of 2Q 2024 48-week placebo-controlled trial is...
ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...
MILWAUKEE, May 09, 2024 (GLOBE NEWSWIRE) -- STRATTEC SECURITY CORPORATION (NASDAQ:STRT) is a market leader of a comprehensive range of...
Conference call begins at 4:30 p.m. Eastern time todayBOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc....
– First patient dosing of SENTI-202, a first-in-class logic-gated treatment for acute myeloid leukemia (“AML”), on track for the second...
PHOENIX, May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to...
REDWOOD CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
